Source comparison
The Unvarnished Truth About CJC-1295 vs MK-677
Here's the honest answer: most comparisons treat these compounds as interchangeable GH boosters when they're mechanistically and pharmacologically distinct. CJC-1295 isn't "injectable MK-677," and MK-677 isn't "oral CJC-1295". They target different receptors,
This comparison does not assign a generated winner or score.
- Here's the honest answer: most comparisons treat these compounds as interchangeable GH boosters when they're mechanistically and pharmacologically distinct. CJC-1295 isn't "injectable MK-677," and MK-677 isn't "oral CJC-1295". They target different receptors, produce different secretion patterns, and carry different risks of tolerance development. The difference between CJC-1295 and MK-677 isn't just administration convenience; it's whether you're amplifying natural pulsatile GH signaling or creating sustained receptor activation that the body wasn't designed to maintain long-term. If your protocol demands preserved circadian GH rhythm and minimal receptor desensitisation, CJC-1295 is the better fit. If oral bioavailability and simultaneous GH/IGF-1 elevation matter more than long-term receptor dynamics, MK-677 is the right tool. The worst approach is selecting based on convenience alone without considering how each compound's mechanism affects downstream study outcomes.